Mon, Dec 22, 2014, 8:52 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

herkyhawk00 8 posts  |  Last Activity: Nov 13, 2014 10:39 AM Member since: Jun 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • As much money as they are dishing out, they should take it over and rid this company of whatever apparent mishaps they are making. They could make a low ball offer for the company and get the company at a premium price.

  • Why don't they have either a button on top and bottom of the dispenser that need to be pressed down by one's lips or either a heat sensor on top and bottom that would detect the warmth of one's lips? Wouldn't that easily cut down on possible tabs not being delivered effectively? Of course, I am not probably really educated on the issues surrounding the problems with the CRL.

    Can anyone inform me of the current features they have in place that would prevent one from "accidentally" dispensing a tablet and having it not fall into the mouth?

  • Reply to

    Ripe for buyout

    by jimdaltroy Oct 2, 2014 9:39 AM
    herkyhawk00 herkyhawk00 Oct 2, 2014 4:17 PM Flag

    This is my feeling. Grunenthal would be smart to offer a takeover bid and get it cheap. Heck, ACRX-04 alone is worth more than the current price and that is again, something that will be provided in a supervised setting.

  • Reply to

    SEC nails 2nd HFT today

    by indiansfan407 Oct 16, 2014 3:51 PM
    herkyhawk00 herkyhawk00 Oct 17, 2014 9:39 AM Flag

    $1 million fine is a joke when you think about the impact it has on the stock and how it effects others. How are they supposed to successfully deal with this illegal activity when you are basically slapping a person on the wrist?

  • Reply to

    Time to load up, while the price is low

    by permit.20841 Oct 17, 2014 12:15 PM
    herkyhawk00 herkyhawk00 Oct 17, 2014 12:28 PM Flag

    permit, whether you have valuable information to share with this board or not, I don't know, but the many posts you continue to put up limit how seriously people take you. Pumpers are just as bad as bashers, imo. Fewer posts would do you justice. Just saying.

  • Why the overreaction? I would think that the stock would have increased as everyone here that follows the stock feels that things weren't handled as well as they could have been. "Incompetence" is a word that has been thrown around quite a bit on here. His "departure" or firing if you want to call it, should be expected. People, we have a great drug with the only hang up being a DEVICE. The drug is approved, it is the DEVICE. King deserved to get removed. They will get this thing figured out and things will be good. Plus, ACRX-04's safety and effectiveness have already been shown. Being that it is going to be distributed under a professional's care, it is another drug that will add to the pipeline. I think the big thing that hurts this stock is that the market is doing well in other areas and people are looking to make money in stocks that are moving. They will come back.

  • Ok, bare with me here. I realize that we are progressing with trying to get the device approved, but what if the company moved forward with the drug just being given to patient by the nurse while we work to get the device approved? I realize that it isn't nearly as attractive as it doesn't allow for the convenience factor, but it also has a longer staying power than Morphine, doesn't it? Again, I realize that the big attraction is also having the device, but since the drug is approved, couldn't we proceed with that?

  • herkyhawk00 herkyhawk00 Nov 13, 2014 10:39 AM Flag

    Ok. Thanks for the insight. With that being the case though, it would be just as easy to have the nurse give the pill wouldn't it? I'm just thinking out loud as the I question whether the CRL for the device should necessarily hold us up from bringing the drug to market?

13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Henry Schein, Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Rite Aid Corporation
NYSEMon, Dec 22, 2014 4:01 PM EST